Sell Suven Pharmaceuticals; target of Rs 571: Geojit

Geojit is bearish on Suven Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 571 in its research report dated February 29, 2024.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *